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Abstract
The nutritional management of children with chronic kidney disease (CKD) is of prime importance in meeting the challenge
of maintaining normal growth and development in this population. The objective of this review is to integrate the Pediatric
Renal Nutrition Taskforce clinical practice recommendations for children with CKD stages 2–5 and on dialysis, as they
relate to the infant from full term birth up to 1 year of age, for healthcare professionals, including dietitians, physicians, and
nurses. It addresses nutritional assessment, energy and protein requirements, delivery of the nutritional prescription, and
necessary dietary modifications in the case of abnormal serum levels of calcium, phosphate, and potassium. We focus on
the particular nutritional needs of infants with CKD for whom dietary recommendations for energy and protein, based on
body weight, are higher compared with children over 1 year of age in order to support both linear and brain growth, which
are normally maximal in the first 6 months of life. Attention to nutrition during infancy is important given that growth is
predominantly nutrition dependent in the infantile phase and the growth of infants is acutely impaired by disruption to their
nutritional intake, particularly during the first 6 months. Inadequate nutritional intake can result in the failure to achieve
full adult height potential and an increased risk for abnormal neurodevelopment. We strongly suggest that physicians work
closely with pediatric renal dietitians to ensure that the infant with CKD receives the best possible nutritional management
to optimize their growth and development.
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The importance of nutrition in the growth
of the infant
There are many reasons for poor growth in infants with
chronic kidney disease (CKD) [1]. One of the most important of these is inadequate nutritional intake. Providing
adequate nutrition is essential, particularly during the
infantile phase of growth when growth is predominantly
nutrition dependent. Inadequate nutritional intake may be
due to anorexia, which is common in CKD, compounded
by gastro-esophageal reflux (GER) with recurrent vomiting. The consequences of poor nutrition during infancy
are suboptimal growth and impaired achievement of final
height potential, abnormal body composition, developmental delay, a worsening of uremic symptoms such as
vomiting, protein-energy wasting, and increased mortality.
This period of nutritional vulnerability may be prolonged
in CKD as the infantile phase of growth may extend from
birth to 2–3 years of age [2]. Normally, linear growth
slows towards the end of the infantile phase, followed by
a transient acceleration of growth around 1 year of age
at the beginning of the childhood phase of growth; the
consequence of this delayed infantile phase in CKD is a
slower overall rate of growth. In addition, many infants
with CKD at birth, often due to congenital anomalies of
the kidney and urinary tract, may be premature or small
for gestational age (SGA) [3]. In a study of 101 infants
with CKD stages 4–5 (CKD4–5), 26 were premature, 18
were SGA, while 10 were both premature and SGA; mean
height standard deviation score (SDS) at birth was − 0.42
[4].
Optimizing the dietary prescription for the infant with
CKD is of vital importance to promote optimal growth and
reverse growth failure if present. While there are many
factors associated with developmental delay and impaired
cognition in this population, nutritional adequacy contributes to improved cognitive outcomes [5, 6]. Physicians
should work closely with pediatric renal dietitians, with
frequent dietetic contact, to ensure the infant with CKD
receives the best possible nutritional management.

Nutritional assessment
Nutritional assessment is the first step in determining the
dietary prescription for the infant. A full description of the
components of nutritional assessment has been published
by the Pediatric Renal Nutrition Taskforce (PRNT) [7],
including methods and tools for the assessment. The three
key critical measurements for the infant are as follows:
euvolemic (dry) weight, with adjustment of measured
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weight when indicated (e.g., when on dialysis or having
nephrotic syndrome), length, and head circumference.
These growth parameters need to be measured routinely in
infants with a minimum recommended frequency of every
6 weeks throughout the first year of life. Weight measurements need to be undertaken more frequently at 2–4
weekly intervals if there are concerns about appropriate
weight gain, or in advanced stages of CKD. Assessment
of euvolemic body weight in infants on peritoneal dialysis
(PD) is a particular challenge and weight gain resulting
from fluid retention may be mistaken for acquisition of
body mass. Indicators of excess weight due to fluid include
edema on physical examination, and hypertension that is
responsive to fluid removal during dialysis.
All measurements must be plotted serially on centile
growth charts. The PRNT recommends using World Health
Organization (WHO) growth charts, the worldwide standard
for tracking growth in children younger than 2 years of age
[8]. Weight-for-length (WFL) reflects body weight in proportion to length and should be monitored. Infants with low
WFL may be underweight or malnourished; conversely, an
infant with high WFL may be overweight or obese. WFL
may also be plotted on WHO charts.
Growth is at its maximum in the first 12 weeks of life,
with length increasing 1.2-fold and weight almost doubling
in a healthy term infant compared to the time of birth [8].
Failure to gain weight is the most obvious signal for nutritional intervention as weight measurements are more sensitive markers of poor growth in infants in whom length measurements are difficult to perform and are often inaccurate.
The longer an infant’s weight is static, the more difficult it is
to regain their centile position on the growth chart: if weight
is static for just 2 weeks in the first 3 months of life, there is
a loss of 1 centile; if static for 4 weeks, 2 centiles are lost [9].
The normal rapid growth rate during the first year (being as
high as 25 cm per year at birth, 18 cm per year at 6 months
of age and slowing to 12 cm per year at 12 months of age) is
even more difficult to regain when nutritional intake is poor
and may lead to irreversible loss of final height potential.
This is especially true when kidney replacement therapy is
necessary during childhood, as this is associated with many
impediments to catch-up growth, even with use of growth
hormone therapy [10, 11]. Head circumference measurements are an additional tool and a small head circumference
may indicate chronic inadequate nutrition, provided there
are no other comorbidities that affect head circumference.
Disorder- or genetic condition-specific growth charts
can be used for infants where growth potential may be
altered, e.g., for those with trisomy 21 (Down syndrome),
Wolf–Hirschhorn syndrome, and Prader–Willi syndrome
[12–14]. Premature infants are also a special case: weight,
length, and WFL for both gestational and chronological age
should be plotted for the first year of life if born from 32 up
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to 37 weeks gestation, and through 2 years of age if born
prior to 32 weeks gestation [15].

Energy and protein requirements
The evidence and rationale for energy and protein requirements in infants have been described by the PRNT [9]. A
novel term, the suggested dietary intake (SDI), has been
adopted for dietary requirements, given the wide variations
in the terms currently used. The lower and upper limits of
the SDI for energy fall within the average daily amount of
energy (i.e., the amount of energy considered sufficient to
meet the needs of half the population) given in various international publications. The lower and upper limits of the SDI
for protein fall within the average published amounts + 2
SD (i.e., the daily amount of protein considered sufficient
to meet the needs of nearly all (97.5%) of the population)
(Table 1). The SDI may be used for formulating the dietary
prescription and assessing the adequacy of dietary intake for
the individual infant.
Some 23 observational and retrospective studies, 18 of
which included infants, reported the effects of specified
energy intake measurements in children with CKD [8],
most reporting that dietary energy intakes of around 100%
of estimated energy requirements in those managed conservatively (i.e., not receiving dialysis) or on PD resulted
in acceptable growth. Four trials studying resting energy
expenditure or basal metabolic rate by indirect calorimetry in children showed no difference for those with CKD
from healthy children after adjustment for lean body mass
[16–19]. Consequently, the PRNT recommends that the initial prescription for energy intake should approximate that of
the healthy infant. In those with suboptimal weight gain and
linear growth, the energy intake should be adjusted towards
the higher end of the SDI to promote optimal growth.

Table 1  Suggested dietary intake (SDI) for energy and protein from
birth at term to 12 months
Month

SDI energy (kcal/
kg/day)

SDI protein (g/kg/
day)

SDI
protein
(g/day)

0
1
2
3
4
5
6–9
10–11
12

93–107
93–120
93–120
82–98
82–98
72–82
72–82
72–82
72–120

1.52–2.5
1.52–1.8
1.4–1.52
1.4–1.52
1.3–1.52
1.3–1.52
1.1–1.3
1.1–1.3
0.9–1.14

8–12
8–12
8–12
8–12
9–13
9–13
9–14
9–15
11–14

For infants receiving PD, the energy contribution from
the dialysate glucose must be considered. Two studies have
estimated energy contributions from dialysate in infants
(7.5 ± 7 and 9.08 ± 4.13 kcal/kg/day, respectively) [20,
21], and it should be included in the calculation for total
energy intake, recognizing the wide variation between
patients and that the precise contribution depends on
glucose concentration of the dialysate, time on dialysis,
number of cycles and dwell times, and peritoneal membrane transporter status. Some infants may benefit from
this additional source of energy if their dietary intake is
insufficient; in contrast, dietary energy may need to be
reduced if there is excessive weight gain.
Any restriction of dietary protein in the early stages
of CKD should be avoided as a low protein intake may
increase the risk of malnutrition, poor growth and proteinenergy wasting. Inadequate protein not only impacts linear
growth, but it also affects body composition, with a preponderance of fat laid down rather than lean tissue [22].
A randomized controlled trial in infants compared the
effects of a low protein versus a normal protein diet over
an average duration of 10 months to determine its potential
impact on CKD progression [23]. At eight months of age,
24 infants (eGFR < 55 mL/min/1.73 m
 2) were randomized
to receive either (what the authors considered to be) a
low protein formula containing 1.4 ± 0.3 g/kg/day, with a
protein-energy (PE) ratio (the percentage of total dietary
energy derived from protein) of 5.6%; or control protein
intake of 2.4 ± 0.4 g/kg/day, PE ratio of 10.4%. While the
differences in protein intake did not have a significant
impact on kidney function, the low protein diet group had
significantly lower SDS for length and growth velocity
compared with controls. To promote optimal growth, it is
strongly recommended that dietary protein intake should
be targeted at the upper end of the SDI. The ranges for
protein SDI outlined in Table 1 are to be used for the initial prescription for infants. The protein intake at the lower
end of the range is considered the minimum safe amount
and should not be reduced below this level. Otherwise, it
becomes the limiting factor for growth.
Due to the dialysate protein losses in infants on PD, protein intake may need to be higher than the SDI for infants
managed conservatively. There are significant protein losses
in the dialysate during PD, ranging from 0.28 g/kg/day in
infants to 0.1 g/kg/day in adolescents [24]. Peritoneal transport characteristics and the increase of peritoneal protein
losses that occur during peritonitis should also be considered
when determining the individual dietary protein prescription. The recommendations for additional protein provided
by the National Kidney Foundation Disease Outcomes Quality Initiative (KDOQI) in 2009 [25] are still valid: for infants
on PD 0.15–0.3 g/kg/day; for infants on hemodialysis (HD)
0.1 g/kg/day.

13

90

In the case of an infant with persistently high blood urea
levels, which may be the result of the infant feeding well and
therefore having a protein intake higher than the upper end
of the SDI range, the protein intake may be adjusted towards
the lower end of the SDI, but not below this minimum safe
level, after excluding other causes of high blood urea levels.
A higher protein intake is not a problem per se if it does not
result in unacceptably high urea levels, but it is important to
recognize that higher protein intakes may negatively affect
acid–base balance, and phosphate intake is also higher with
a high protein intake, which may lead to hyperphosphatemia.
In a study of 20 children on PD, dietary protein intake was
negatively correlated not only with plasma bicarbonate, but
also with total body bone mineral density, bone mineral content, and fat-free mass [26]. It is not expected that infants
with CKD have urea levels in the normal range. High urea
levels may indicate an excessive dietary protein relative to
energy intake but may also be secondary to dehydration,
steroid therapy or a catabolic state due to inadequate energy
intake. In the latter case, firstly an increase in non-protein
dietary energy may reduce urea levels. If this intervention is
not sufficient then protein intake may be cautiously reduced,
keeping in mind the minimum protein requirements for adequate nutrition and growth, while preserving energy intake.
Infants with CKD stage 5 may require dialysis if dietary
manipulation to reduce persistently high urea levels compromises their nutritional intake. Urea levels that are lower
than expected for the stage of CKD may indicate insufficient
dietary protein.

Vitamins, minerals and trace elements
Little is known about the requirements for vitamins, minerals and trace elements in infants with CKD. Currently, the
advice provided by KDOQI [25] would be reasonable to follow: at least 100% of the dietary reference intake for healthy
children, with supplementation if dietary intake alone is
insufficient; plus a water-soluble vitamin supplement for
those with CKD stage 5 and on dialysis. An exception is
vitamin A, as increased retinol levels have been reported
in infants [27] and children with CKD and on maintenance
dialysis, even without supplementation, with the associated development of hypercalcemia [28]. These high circulating levels of retinol are possibly a result of decreased
glomerular filtration of the retinol–retinol-binding protein
complex; reduced conversion of retinol to retinoic acid; and
an accumulation of retinol-binding protein [29]. Vitamin D
deficiency is common in CKD and evaluation, prevention
and treatment of vitamin D deficiency is complex. Recommendations for the assessment of vitamin D status, optimal
concentrations of 25-hydroxyvitamin D, and recommendations for native and active vitamin D supplementation are
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described elsewhere [30, 31]. Foods fortified with vitamin
D may inadvertently lead to a cumulative excess of vitamin D, with consequent hypercalcemia [30]. These dairy
products, margarines, and breakfast cereals do not feature
largely in the infant’s diet; however, infant formulas are a
significant source of vitamin D (around 1.5 µg/100 mL) and
must be taken into account before prescribing vitamin D
supplements.

Feeding the infant
Breastmilk and infant formula
Breastfeeding is the preferred method for feeding an infant
with CKD, as recommended for the healthy population [32].
Infants with CKD2–5D may benefit from its low renal solute load, particularly with respect to its low phosphate and
potassium content. Mothers who wish to breastfeed should
be supported by all members of the medical and nursing
teams. While many infants with CKD have been successfully breastfed for several months, some mothers can find
it too stressful to breastfeed: they may be concerned that
they do not know how much milk their baby is getting (and
this may also be a negative view given by some healthcare
professionals); or the sick baby may not latch onto the breast
well. In such cases, reassurance must be given that the situation is being carefully monitored, and that supplementary
feeds will be given as necessary. Breastfed infants need to
feed every 2 to 3 h in order to obtain sufficient nutrition
to maintain normal growth. If breastfeeding is not possible, the mother may wish to express her breast milk. If it
becomes clear that the intake from breastfeeding alone is
inadequate, or there is insufficient expressed breast milk
(EBM), as demonstrated by a falling of the infant’s weight
centile, then supplementary feeding should be provided with
a whey-dominant infant formula (IF). If the mother does not
wish to breastfeed at all, this type of IF can be given as the
sole source of nutrition from birth. Whey-dominant IF has
a protein and electrolyte content closer to that of breastmilk
than casein-dominant IF, so is the preferred alternative and
may be beneficial beyond the first year of life. Of course,
whenever a mother wishes to continue breastfeeding, this
should be prioritized and incorporated into the feeding plan,
provided the infant’s nutritional intake is not compromised.
Soya-based IF are not recommended under 12 months of
age unless there is a specific medical indication, as there are
concerns about their high phytoestrogen content.
Infants with CKD are prone to vomiting resulting from
GER, delayed gastric emptying and gut dysmotility associated with decreased clearance of polypeptide hormones and
cytokines [33, 34]. Additionally, for those on PD, vomiting may occur due to raised intra-abdominal pressure [35].

Pediatric Nephrology (2023) 38:87–103

91

Normally, an IF feed volume of 150 mL/kg is sufficient to
provide optimum nutrition. When growth is faltering, it is
tempting to offer a higher volume of formula to improve
nutritional intake. Unfortunately, this practice can be counterproductive as this higher volume often exacerbates vomiting and GER. Infants may actually benefit from a reduction
in feed volume with an increase in the energy density of the
feeds as described below.
Caution is needed with the polyuric infant who has a
demand for fluids that is higher than normal. It would be
unwise to attempt to meet all fluid requirements from IF as
the infant will respond with increased vomiting. It is best to
offer the necessary additional fluid as water between feeds,
though some infants will also require additional electrolytes,
principally sodium, due to high urinary or dialysate losses.
The polyuric infant will readily drink water to maintain
hydration.

Concentrating feeds
When infants are reluctant to complete their feeds, or when
there is a prescribed fluid restriction or a more energy and
nutrient-dense feed is required to meet nutritional requirements, EBM and IF should be fortified.
Most standard IF are reconstituted to an approximate
13% concentration (i.e., 13 g powder to 100 mL water,
providing 67 kcal and 1.3 g protein per 100 mL). The
formula can be fortified to provide more nutrition in a
given volume by concentrating up to 20% (i.e., 20 g powder to 100 mL water). Daily increases may be done in
steps of 1–3%, depending on the infant’s tolerance of formula changes. Table 2 shows the effects of concentration
on the formula profile. Infant formula powder may also

be added to EBM at a concentration of 3–6% (i.e., 3–6 g
infant formula powder to 100 mL EBM), increasing the
total energy density up to 1 kcal/mL (Table 3). Breastmilk
fortifiers may be used for preterm infants, contributing
around 4 kcal/g, 0.26 g protein/g (follow manufacturer’s
instructions for addition to breastmilk). They are designed
to provide the increased requirements of the preterm infant
for energy, protein, sodium, calcium, phosphate, vitamin
D, and other nutrients. Their use must be carefully considered in the preterm infant with CKD.
The concentration of formula should be done in a gradual manner in order to maximize acceptance with respect to
taste and gut tolerance since the resulting increase in osmolality [36] may cause diarrhea or exacerbate vomiting and
GER. As the concentration of the formula is increased by the
addition of more IF powder to a given volume of water, the
renal solute load of the formula is also increased and may
lead to excessive intakes of phosphate, potassium, and other
minerals and vitamins, with toxic levels of vitamin A being
of particular concern [28].
Alternatively, a patient-specific profile for energy and
protein can be designed by using an IF at a normal concentration (or EBM if available) and adding powdered protein modules and/or energy modules (glucose polymers, fat
emulsions, or combined carbohydrate and fat preparations).
This method of fortification is preferable if concentrating the
IF provides an intake of vitamin A, potassium, or phosphate
beyond desirable levels. With this approach, it is essential to
ensure that there is a sufficient intake of other vitamins, minerals, and trace elements. An example is given in Table 4.
A simple recipe and caregiver education are required to
reduce errors in formula preparation [37]. Commercially
available energy and nutrient-dense liquid infant formulas,

Table 2  Concentrating whey-dominant infant formula (average composition per 100 mL)
Concentration

Energy (kcal)

Protein (g)

% CHO

% Fat

Na (mg)

K (mg)

Ca (mg)

PO4 (mg)

13 g powder/100 mL water (13%)
15 g powder/100 mL water (15%)
17 g powder/100 mL water (17%)
20 g powder/100 mL water (20%)

66
76
86
102

1.3
1.5
1.7
2.0

7.2
8.3
9.4
11.1

3.6
4.2
4.7
5.5

18
21
27
28

69
80
90
106

51
59
67
78

24
28
31
37

Effects of concentration on osmolality (mOsm/kg): 13% = 296; 15% = 339; 17% = 387; 20% = 451; ?upper limit = 500?

Table 3  Fortifying expressed breastmilk with whey-dominant infant formula (average composition per 100 mL)
Concentration

Energy (kcal)

Protein (g)

% CHO

% Fat

Na (mg)

K (mg)

Ca (mg)

PO4 (mg)

100 mL mature breastmilk
Plus 3 g infant formula powder
Plus 6 g infant formula powder

69
84
100

1.3
1.6
1.9

7.2
8.9
10.5

4.1
4.9
5.8

15
20
25

58
74
91

34
46
57

15
24
32

Breastmilk analysis from Public Health England: McCance and Widdowson’s The Composition of Foods Integrated Dataset 2019 https://www.
gov.uk/government/publications/composition-of-foods-integrated-dataset-cofid
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Table 4  Modular approach to fortifying whey-dominant infant formula compared with concentrating formula (average composition per 100 mL)
Concentration

Energy (kcal)

Protein (g)

% CHO

% Fat

Na (mg)

K (mg)

Ca (mg)

PO4 (mg)

13 g infant formula powder (13%)
0.8 g protein powder
4 mL fat emulsion
4 g glucose polymer
per 100 mL
20 g infant formula powder (20%)

67
3
18
15
103
102

1.3
0.7
0
0
2.0
2.0

7.2
0
0
3.8
11.I
11.1

3.6
0
2.0
0
5.6
5.5

17
0*
0
0
17
26

68
0*
0
0
68
106

51
0*
0
0
51
78

25
0*
0
0
25
37

*

Values vary according to brand of protein powder

when available, may be useful as supplements to provide
additional energy and protein.
To achieve optimal growth in the healthy infant with
appropriate deposition of lean and fat tissue, the PE ratio
of the infant formula should ideally be between 7 and 12%;
a high PE ratio is required for accelerated weight gain or
catch-up growth. The WHO suggests that a rate of weight
gain of 10 g/kg/day requires a daily intake of 126 kcal/kg,
2.8 g protein/kg, and a PE ratio of 8.9% [22]. In infants with
CKD, the addition of non-protein energy sources (carbohydrate and fat) to a formula can be used to control elevated
blood urea or potassium levels resulting from poor energy
intake, catabolism, and consequent tissue breakdown, which
lowers the PE ratio. In these situations, it is important to
ensure that at least the SDI for protein is provided. A PE
ratio of 5.3–6.4% has been shown to support weight gain and
linear growth in children aged 0–2 years, provided at least
100% of protein requirements were given [38]; the lower PE
ratio reflected an increase in energy provision rather than a
low protein intake.
The impact of adding carbohydrate and fat supplements
on the osmolality of IF is largely unknown, though one study
has shown the addition of 2 g glucose polymer powder per
100 mL IF increased the osmolality by 31 mOsm/kg [36].
It is recommended that carbohydrate modules are added in
increments, e.g., 1% daily (1 g added to 100 mL formula or
EBM per day, yielding an additional 4 kcal/100 mL). Such
gradual increase allows for the concentration at which the
infant becomes intolerant, as reflected by the development

of loose stools/increased vomiting, to be identified. If glucose polymers are not available, then glucose or sucrose may
be used, but as the osmotic effect of mono- and disaccharides on the gut is greater than a polymer, less can be used
per given volume of formula. Also, the intense sweetness
of mono- and disaccharides may limit their use. The dental
hygiene of the infant’s emerging teeth must also be considered. Tolerance to carbohydrate concentration of the feed
depends on the type of supplement; the age of the infant;
the maturity and absorptive capacity of the gut, with some
infants more tolerant of a more rapid addition of carbohydrate than others (Table 5).
The fat source of commercial fat emulsions is polyunsaturated oils with a favorable omega-3 to omega-6 fatty
acid ratio. They should also be added incrementally, e.g.,
1% daily (1 mL added to 100 mL formula or EBM per day)
to provide an increase of 0.5 g fat per 100 mL (an additional
5 kcal/100 mL). The increased fat content may delay gastric
emptying and cause nausea and vomiting. If emulsions are
not available, then oils may be used, but little is known about
the type and amount that can be added to IF. Oils will have
little effect on osmolality, but will settle out on standing.
A bottle of IF fortified with oil must be shaken frequently
throughout the feeding period to ensure that the oil is dispersed and, therefore, consumed.
Powdered protein modules are added to formulas or
EBM to provide a specific amount of protein per kg of body
weight. If they are used in infants, for instance to compensate for protein losses in dialysate, they should be added in

Table 5  Energy modules added to whey-dominant infant formula
Energy module

Age

Amount of CHO/fat module added to formula

Final concentration CHO/fat
in formula (% or g/100 mL)

Glucose polymer

< 6 months
6 months–1 year
< 1 year
< 1 year
< 1 year

3–5 g (+ 7 g CHO from infant formula)
5–8 g (+ 7 g CHO from infant formula)
1–2 g (+ 7 g CHO from infant formula)
2–3 g (+ 7 g CHO from infant formula)
3–5 mL (+ 3.5 g fat from infant formula)

10–12
12–15
Maximum 8–9
Maximum 9–10
5–6

Glucose
Sucrose
Fat emulsion (50% fat
content)

13

Pediatric Nephrology (2023) 38:87–103

small increments of 0.1 g protein/kg/day, with urea levels
serially monitored to detect excessive intake. Some protein
modules may contain appreciable amounts of phosphate so
serum phosphate levels may be impacted if large amounts
are used.

Complementary feeding
Exclusive breastfeeding for the first six months of life, is recommended by WHO [32], and solid foods should be introduced to the infant with CKD as for healthy infants. However, the age when solids are introduced should be managed
individually. Delayed exposure to pureed and more textured
foods may cause a delay in the development of oral motor
skills and result in feeding problems [39]. The nutritional
content of any solid foods taken must be balanced against
that provided by the formula in order to maintain an optimum intake of energy, protein and other nutrients during
the weaning period. A healthy balanced diet (adapted to any
phosphate or potassium restrictions that may be required)
with a wide range of food choices should be offered, with
a variety of textures according to the infant’s cues and oral
motor skills. However, the infant with CKD may be reluctant to take an oral diet for a number of reasons. Acidosis,
anemia and uremia negatively influence oral intake if not
corrected. Appetite for both feeds and solids may be also be
impacted by persistent GER and gut dysmotility. It seems
likely that the reduced smell and taste sensations recognized
in older children with CKD [40], which worsens as CKD
progresses, also affect the infant’s appetite. The polyuric
infant preferentially drinks large amounts of water, which
also reduces appetite. Finally, the many medications that
may be required further affect what the infant is prepared
to have in its mouth and swallow. The combination of these
elements can lead to food aversion that may not resolve until
normal kidney function is restored with a transplant.

Tackling poor growth
The PRNT recommends prompt intervention once there is a
deterioration in the infant’s weight centile. The first step is
to address any correctable medical causes of reduced dietary
intake and optimizing dialysis. GER may be treated with
alginates, antacids, histamine H2 receptor antagonists, proton pump inhibitors, and prokinetics. Sucralfate, although an
effective treatment for GER, should not be used in infants
with CKD since it contains aluminum hydroxide that may
lead to aluminum intoxication in kidney failure, which has
been associated with bone and neurological disease. Infants
with renal dysplasia may have significant urinary losses of
salt and water and become both salt and water depleted.
Sodium is an important growth factor and salt deprivation
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inhibits growth, even if the intake of energy and other
nutrients is sufficient. This failure to gain weight can be
reversed with sodium and water supplementation. Height
SDS was shown to improve by 1.83 SD in 24 polyuric
infants (92% with obstructive uropathy and dysplasia) over
a 2-year period when formula was supplemented with up to
4 mmol/100 mL of sodium chloride and/or sodium bicarbonate [41]. Correction of acidosis with base supplementation
is also necessary. Acidosis is common in all causes of CKD
when GFR falls below 25 mL/min/1.73 m
 2, and even moderate acidosis is associated with poor growth due to negative
effects on bone metabolism and muscle synthesis. KDOQI
recommends maintaining serum bicarbonate at 22 mmol/L
or higher [25]. Inadequate PD may be an important factor
for undernutrition and poor growth, and in certain cases, a
switch to intensified, often daily, HD may be indicated.
If poor growth persists, even when the above issues
have been addressed, this is most likely due to inadequate
nutritional intake. In this case, nutritional supplementation
should be started.

Oral nutritional supplementation
To improve nutritional intake, EBM can be supplemented by
the addition of IF powder; IF can be concentrated or fortified with energy and protein modules (Tables 2–4). Foods
with high nutritional value should be offered, ensuring the
appropriate texture for infants. High biological value protein
foods such as meat, poultry, fish, eggs, and milk products,
e.g., cheese, yogurt, fromage frais, provide the right proportion of essential amino acids for growth and protein repletion. Low biological value protein foods from plant sources
have an incomplete profile of essential amino acids: pulses
(peas, beans, lentils); ground nuts or nut butters; cereals
(grains) such as rice, pasta, couscous; potatoes and other
starchy roots and tubers; fruits and vegetables. However,
these foods may need to be given preferentially if there is a
need for reduced protein intake in the case of rising blood
urea levels. The continued provision of breastmilk and IF
will ensure a balance of amino acids to maintain growth.
The amount of some of these foods may need to be limited
due to their phosphate and potassium content. Savory foods
can be fortified with energy by adding vegetable margarines
or oils, preferably those high in omega-3 fats, e.g., soya,
walnut, linseed, rapeseed, or high in monounsaturated fat,
e.g. olive oil. Sugar, jams, syrups and glucose can be added
to sweet foods. Energy modules can also be added to sweet
and savory foods. Glucose polymers can be added to water,
starting with 5% (5 g added to 100 mL) and increasing to
10% for the younger infant and 15% for the older infant as
tolerated and needed. Sugar and glucose may also be used,
but the quantity may be limited due to their sweet taste; these
infants prefer salty, savory flavors over sweetness.
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Enteral tube feeding
Infants who are unable to meet their nutritional requirements
orally should be started on supplemental or exclusive enteral
tube feeding in order to improve their nutritional status. The
PRNT suggests that there should be prompt intervention
once a deterioration in weight centile is noted. Intervention
may be appropriate at any age but is especially important in
infants, where it is likely to reverse poor linear growth. Eight
retrospective studies, in which tube feeds were either supplemental to oral intake or provided up to 100% of energy and
protein requirements, showed improvement in weight and
body mass index SDS in children < 2 years [4, 38, 42–47].
Six of these studies also showed an improvement in height
SDS [4, 38, 42, 44, 45, 47].
A nasogastric (NG) tube is the preferred option for shortterm enteral feeding (EF), while a gastrostomy device (GD) is
preferable for long-term EF. An NG tube may be considered as
a bridging option to a long-term GD, improving the nutritional
status of the infant in preparation for placement of the GD. The
healthcare team must involve the infant’s parents/caregivers
in the decision to tube feed, explaining why it is necessary,
the process of tube feeding, the different types of tubes and
devices available, and emphasizing the possible benefits,
including a reduction in parental anxiety around oral feeding;
using the tube for the administration of medications and any
additional fluid that might be needed; improving growth, and
thus reducing the time to reach the desired size for a kidney
transplant. In addition, complications with the use of EF tubes
must be explained, especially the risk of aspiration if there is
a displacement of the NG tube into the airway.
Preparations and investigations prior to insertion of a GD
and techniques used for their insertion are fully described
elsewhere by the PRNT [48]. Table 6 summarizes recommendations for placement of a GD in the child who is receiving PD. There is no evidence for when it is safe to start using
a GD post-insertion in infants with CKD or on dialysis; the
European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) suggests 4–6 h post-insertion for the general pediatric population [49]. The PRNT
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suggests starting with water or other appropriate clear fluid
2 h post-insertion; 30 mL would be appropriate for an infant.
If this is tolerated, then at 3 h, 50% of the usual feed volume
rate can be given as water. At 6 h, the formula or EBM can
be given instead of water and the amount gradually increased
until the full prescription is achieved.
Tube feeding may be exclusive or supplementary to oral
feeding. Gravity bolus feeds can be given either as supplementary feeds after meals or to complete unfinished oral
feeds, or all the infant’s nutrition can be given as boluses. If
EF pumps are available, overnight continuous feeds can be
given through the GD. This takes away the anxiety of parents/caregivers in their battle to feed an infant who is reluctant or refuses to feed by mouth. Continuous NG overnight
feeding at home poses a significant risk for aspiration of the
formula/EBM if used unsupervised, which can be fatal. A
local risk assessment should be conducted.
Infant formulas and EBM are preferred for EF and can be
supplemented, if necessary, as described above. If caregivers
wish to prepare their infant’s tube feeds by blending foods,
this should be done under the supervision of a qualified dietitian who will advise about safety issues with this practice,
including nutritional quality, microbial contamination and
appropriate equipment and administration [50]. The use of
commercial baby foods would be preferable as they are sterile and have a known nutritional profile.
Although EF can ensure that an infant is getting their
complete nutritional prescription, it is often associated with
long-lasting feeding difficulties: chewing and swallowing
problems, and food refusal [51]; and poor development of
oral motor skills [39]. Ongoing oral stimulation is essential
in infants who have prolonged tube feeding to help them to
transition to normal feeding once they have had a successful transplant [52, 53]. Even when an infant is dependent on
tube feeds, caregivers can encourage continued oral intake
by offering drinks from a bottle or cup and pureed or more
textured foods when developmentally ready; engaging in
messy play and joining family mealtimes, even if nothing is
eaten; giving positive oral experiences, such as touching and
kissing the mouth area; giving non-nutritive oral stimulation

Table 6  Summary of PRNT recommendations for placement of gastrostomy devices while on PD [45]
In a child who is likely to need PD, and in whom enteral tube feeding is required, gastrostomy tube insertion by PEG or RIG should, whenever
possible, be performed before placement of a PD catheter
A gastrostomy device can be inserted simultaneously with a PD catheter if the gastrostomy is placed by open surgery or PLAG
In a child who is already receiving PD an open or laparoscopically assisted gastrostomy is the preferred procedure
Antibiotic prophylaxis, based on local antibiotic sensitivities, is recommended for all children undergoing gastrostomy placement
Children who are already established on PD or who receive a gastrostomy at the same time as a PD catheter should receive broad spectrum
antibiotic and antifungal prophylaxis in the peri-operative period of gastrostomy placement
PD should be withheld for 24 h or longer after gastrostomy placement if it is clinically safe to do so
PD peritoneal dialysis, PEG percutaneous endoscopic gastrostomy, PLAG percutaneous laparoscopic assisted gastrostomy, RIG percutaneous
radiologically inserted gastrostomy
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such as a pacifier to suck, mouthing toys; encouraging selffeeding, licking, and tasting of foods with no pressure to
swallow. Support from a speech and language therapist, psychologist, or family therapist can be helpful when there are
significant feeding difficulties [39].
If growth continues to be poor, despite the provision of
adequate nutrition through supplementation of the oral diet
or enteral tube feeding, growth hormone therapy may be
considered in the infant to enhance growth [11].

Management of vomiting
Vomiting can be an ongoing problem for some infants, even
in those who are receiving tube feeding. This persistent
vomiting becomes very stressful for families as well as having a negative impact on oral feeding for the infant. Having exhausted the medical therapies outlined above, some
strategies that may help are as follows: give smaller, more
frequent bolus feeds; concentrate the formula to allow a
reduction in the feed volume; slow delivery of the feed by
continuous infusion via EF pump [39]; reduce the rate of
delivery and give the feed over a more extended period of
time. Continuous feeding may lead to higher pH values in
the stomach which can promote bacterial growth, particularly affecting those with significant dysmotility [49]. It is
therefore recommended that there is sufficient time off the
EF pump to allow the stomach pH to return to normal.
If growth is negatively affected by persistent vomiting, upper gastrointestinal contrast study and a pH study
should be performed to exclude malrotation and to define
the severity of GER. Post-pyloric, or trans-gastric, feeding
via nasojejunal or gastrojejunostomy may be considered, but
ESPGHAN recommends this route of feeding only if there is
severe GER disease, gastroparesis or gastric outflow obstruction [49] because of frequent complications. Nasojejunal
tubes are easily displaced and migrate up into the stomach;
gastrojejunal tubes or jejunostomy are the preferred alternatives. For both gastrojejunal and nasojejunal tubes, formula must be delivered by continuous infusion, as boluses
entering the jejunum are poorly tolerated. In a study of 101
infants diagnosed with CKD in the first 6 months of life, 13
required a Nissen fundoplication for persistent vomiting [4].

Dietary modifications
The PRNT has published a full account of the nutritional
management of calcium and phosphate [54] and potassium
[55]. While dietary intakes may need to be adjusted to maintain serum levels within the age-appropriate normal range,
restrictions should be limited as much as possible so as not
to worsen any pre-existing reluctance to eat. Any changes in
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nutritional management should be based on trends of serial
results rather than a single result and without compromising
the infant’s overall nutritional status.

Calcium
Calcium is necessary for bone mineralization and to prevent fractures [56]; therefore, a low dietary calcium intake
is of concern. Conversely, a high calcium intake may lead
to vascular calcification, progressive vessel stiffness and left
ventricular failure [57–61]. Calcium intake in the infant is
unlikely to be excessive or deficient if nutritional requirements are met from breastmilk, IF, and some contribution
from solid foods. Calcium intake should provide at least
100% of the SDI (Table 7) but be no more than twice the
SDI. In special circumstances, such as for infants with
mineral-depleted bone, a higher calcium intake of > 200%
SDI may be needed to replenish bone calcium stores and
is likely to require calcium supplementation in addition to
dietary calcium. In the case of persistent hypocalcemia or a
high parathyroid hormone level, calcium intake should be
increased above 200% SDI for a short period under close
medical supervision [54]. Additional calcium can be provided through calcium supplementation and high calcium
dialysate. The use of calcium-rich foods, such as dairy
products (cheese, yogurt, fromage frais) which infants are
most willing to eat, may need to be limited as these will
also increase dietary phosphate intake. Absorption of calcium requires adequate vitamin D and often requires supplementation (usually both native and active forms) [30, 31].
It should be noted that frequent vomiting may lead to metabolic alkalosis, which in turn might affect the interpretation
of serum calcium levels—ionized calcium levels must be
measured so that hypocalcemia can be detected and managed appropriately.
In the case of persistent mild to moderate hypercalcemia, management is mainly medical: reducing or stopping
calcium supplements, calcium-based phosphate binders,
and native and active vitamin D, and using lower calcium
dialysate. A temporary reduction of dietary calcium may
also be necessary. If hypercalcemia is severe and persists, a
nutritionally complete specialized low calcium formula may
fully or partially replace IF or breastmilk (mothers should be
supported to express and safely store their breastmilk until
it can be fed to their infant). In addition to dairy products,
Table 7  Suggested dietary intake (SDI) for calcium and phosphate
Age (years)

SDI calcium (mg/day)

SDI phosphate (mg/
day)

0 to < 4 months
4 to < 12 months

220
330–540

120
275–420
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other calcium-rich foods may need to be restricted: greenleafy vegetables, beans, ground nuts and nut butters, and
calcium-fortified foods. Using deionized or distilled water
to reconstitute formula also reduces calcium intake. Regular
assessment of dietary calcium is required, especially when
calcium intake is reduced below the SDI.

Phosphate
Table 7 shows the SDI for phosphate. Serum phosphate
is likely to be within the normal range if the infant is fed
breastmilk or whey-dominant IF. However, phosphate retention begins early in the course of CKD, and if there is either
persistent hyperphosphatemia or persistent hyperparathyroidism in the presence of normal calcium levels, dietary
phosphate should not exceed the SDI for young infants,
and intake should be reduced to the lower end of the SDI
range for infants older than 6 months [54]. The introduction of complementary solid foods that are easy to swallow,
particularly soft dairy foods and eggs, increases phosphate
intake. Whole grain cereals, although higher in phosphate
than refined varieties, need not be restricted as the inclusion
of fiber in the diet is beneficial. Foods with a suitably lower
phosphate content are shown in Table 8. Processed foods
containing phosphate additives should be avoided as they are
a source of highly bioavailable inorganic phosphate, which
is almost completely absorbed [62].
Although breastmilk and whey-dominant IF are naturally low in phosphate (15 mg/100 mL and average
30 mg/100 mL, respectively), a specialized renal-specific
low potassium infant formula, that also has a lower phosphate content, may be given so that dietary restrictions can
be liberalized, allowing a greater variety of food choices,
which may encourage more normal development and behaviors around food. Table 9 shows the composition of a typical
renal-specific formula and how to adapt a whey-based IF to
reduce phosphate content. Diluting the IF needs to be done
with extreme caution as this also reduces the energy, protein,
vitamin, and mineral content of the formula. Energy and protein modules must be added, together with a suitable vitamin
and mineral preparation, to restore the full composition and
maintain nutritional adequacy.
Renal-specific low potassium infant formulas should not
be used as the sole source of nutrition as their low potassium content may cause a precipitous fall in serum potassium. Finally, phosphate binders may be required with more
advanced CKD and the development of hyperphosphatemia
(added to bottle feeds and moist foods), as any dietary
restriction may have a negative impact on an existing reluctance to eat and further decrease intake of solids.
In the case of hypophosphatemia, dietary phosphate
should be increased so as to achieve age-appropriate serum
phosphate levels. The easiest way to do this is to offer more
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milk- and egg-based foods; phosphate supplements may be
necessary if this approach is not tolerated or does not correct
the hypophosphatemia.

Potassium
Infants are at risk for developing hyperkalemia in association
with moderate to severe CKD. Whereas a reduced potassium
intake is usually indicated, hyperkalemia can result from
catabolism when there is deficient energy intake [9]. This
can be resolved by the addition of energy modules to the
infant’s usual formula or EBM (Table 5). There are no data
to suggest potassium requirements for children with CKD.
Extrapolating from adult data, KDOQI recommends an initial target potassium intake of 1–3 mmol/kg/day for infants
to maintain a normal serum concentration [25]; however,
the PRNT recommends that dietary potassium intake is only
adjusted if the serum potassium level is outside the normal
range: 3.5–5.0 mmol/L in infants, and 3.5–5.5 mmol/L in
neonates, based on serial measurements [55].
Before adjusting the diet, the many non-dietary causes
of hyperkalemia, such as pseudohyperkalemia, medications
that affect serum potassium (e.g., some laxatives, angiotensin-converting enzyme inhibitors, renin–angiotensin–aldosterone system inhibitors, and beta-blockers), metabolic acidosis, constipation, and the dialysis prescription, should
be addressed [55]. Severe, life-threatening hyperkalemia
requires rapid medical intervention with discontinuation of
all sources of potassium from medications, parenteral fluids,
formulas, and food.
Serum potassium is likely to be within the normal range
in the infant with mild to moderate CKD if fed breastmilk
or whey-dominant IF. However, if there are persistent episodes of hyperkalemia, reduced intake of potassium can be
achieved by gradually replacing some of the breastmilk or IF
with a specialized renal-specific low potassium IF (Table 9).
Serum potassium levels need to be regularly checked to
ensure they are maintained in the normal range. Attention
also needs to be paid to the changes in nutrient profile, as
there is often decreased calcium and phosphate content and,
for some products, an increased sodium content due to the
renal-specific formula. If a renal-specific low potassium IF
is not available, a whey-based IF can be adapted to reduce
its potassium content (Table 9). As described above, diluting an IF needs to be done with great caution as this also
reduces the energy, protein, vitamin, and mineral content.
If EBM is diluted, it too must have nutritional adequacy
restored by the addition of energy and protein modules and
an appropriate vitamin and mineral supplement given. There
is no evidence that reducing maternal dietary potassium has
any impact on the potassium content of breastmilk. Generally, a renal-specific low potassium IF should only be used
as the sole source of nutrition in the short term (hours rather

Breastmilk, whey-dominant infant formula

Continue beyond 1 year
Cheese, yogurt

Milk

Food type

Avoid

Food additives

Potassium additives—bioavailability
90–100%

Avoid

Apple, blueberries, lychees, pear, pineapple, Portion size may need to be controlled
raspberries
High K: apricot, banana, mango, melon,
orange, papaya, strawberries
Fruit

Any type, e.g., apple, apricot, banana, blueberries, lychees, mango, melon, orange,
papaya, pear, pineapple, raspberries,
strawberries
Phosphate additives—bioavailability up to
100%

Broccoli, butternut squash, cabbage, carrot,
cauliflower, courgette, pumpkin, swede
High K: avocado, brussels sprouts, okra,
plantain, sweet potato, tomato, yam

Portion size may need to be controlled

Portion size may need to be controlled

Vegetables

Almonds, hazelnuts, peanuts, walnuts;
sesame and sunflower seeds; tahini paste
High K: pumpkin seeds

Any type, e.g., avocado, broccoli, brussels
sprouts, butternut squash, cabbage, carrot,
cauliflower, courgette, okra, plantain,
pumpkin, swede, sweet potato, tomato,
yam

Portion size may need to be controlled Any type, e.g., almonds, hazelnuts, peanuts, Nuts and seeds
(ground, pastes,
walnuts; pumpkin, sesame, sunflower
butters)
seeds; tahini paste

Lentils, split peas, chickpeas; cannellini, red Portion size may need to be controlled
kidney beans; tofu; houmous
High K: black eye, broad, butter beans

Pulses, legumes

Any type, e.g., lentils, split peas, chickpeas;
black eye, broad, butter, cannellini, red
kidney beans; tofu; houmous

Portion size may need to be controlled

Whole egg

Fresh, unprocessed, any type

Portion size may need to be controlled

Continue beyond 1 year

Comment

Eggs

Meat, chicken, fish

Baby cereals; rice, pasta, noodles, couscous,
millet, bulgur wheat, semolina, tapioca;
bread, chapattis
High K: potatoes—cut into small pieces and
double boil, discard cooking water

Any type

Breastmilk, whey-dominant infant formula

Lower potassium options

Egg white

Portion size may need to be controlled Fresh, unprocessed, any type

Baby cereals; rice, pasta, noodles, couscous, Starchy foods
millet, bulgur wheat, semolina, tapioca;
bread, chapattis; potatoes

Portion size may need to be controlled Cottage, cream, ricotta cheese; paneer

Lower phosphate options

Comment

Table 8  Controlling phosphate and potassium intakes
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Table 9  Specialized and adapted infant formulas per 100 mL
Energy (kcal)

Protein (g)

CHO (g)

Fat (g)

Na (mg)

K (mg)

Ca (mg)

PO4 (mg)

Typical whey-dominant infant formula
3 scoops powder (13 g) per 100 mL

66

1.3

7.2

3.6

17

68

51

25

Typical low calcium infant formula
13 g powder per 100 mL

66

1.9

7.0

3.4

29

84

<7

46

Typical renal-specific low potassium infant formula
13 g powder per 100 mL
65

1.0

8.2

3.1

31

14

16

12

2.5
0
1.3
0
3.8

12
0*
0
0
12

47
0*
0
0
47

35
0*
7
0
42

17
0*
0
0
17

Diluted whey-dominant infant formula providing less calcium, phosphate and potassium
2 scoops powder (9 g)
47
0.9
5.0
0.5 g protein powder
2
0.5
0
2.5 mL fat emulsion
11
0
0
2 g glucose polymer
8
0
2.0
68
1.4
7.0
Per 100 mL

A vitamin supplement (without vitamin A) and mineral supplement may be necessary to achieve nutritional adequacy. Calcium content may
increase depending on calcium content of local water supply. The figures here assume using deionized or distilled water for reconstitution (check
calcium content of any mineral supplement)
*

Values vary according to brand of protein powder

than days) as the low potassium content may cause a rapid
fall in serum potassium. If used solely in the initial treatment of moderate to severe hyperkalemia, whey-dominant
IF or breastmilk should be introduced as soon as serum
potassium levels allow. Some infants may benefit from the
extended use of a renal-specific formula; however, caution is
advised as in addition to a decreased potassium intake, there
will be decreased calcium and phosphate intakes and, with
some formulas, an increased sodium intake. An adult renalspecific low potassium formula can also be used in infants
to reduce serum potassium [63], but the nutritional profile
needs to be carefully checked for its suitability.
An alternative therapeutic approach to address hyperkalemia is with the use of a potassium-binding resin (sodium
polystyrene sulfonate or calcium polystyrene sulfonate). The
resin is added to the liquid feed with active mixing, followed
by at least 30 min for the resin to settle, and decanting the
liquid feed once the gel has formed. Studies have shown a
variable reduction in serum potassium levels in infants fed
breastmilk and IF using this approach, but there are also
other effects: an increase in serum iron, sodium, sulfur, and
pH and a decrease in calcium, copper, manganese, phosphate, and zinc [64–72]. Pre-treatment of IF with these resins has also resulted in hypokalemia, hypernatremia, and
hypocalcemia [64]. It is advisable to monitor electrolytes
and micronutrients that may be altered by these potassium
binders, but they are rarely used for long-term management
as they carry a high risk of causing severe constipation and
even bowel necrosis. More recently, pre-treatment with
patiromer (a calcium-based cation exchange polymer) has
been found to decrease the potassium content of IF, with
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an increase in calcium, magnesium, sodium, and phosphate
[73].
Dietary potassium intake increases with the introduction
of solid foods, the first foods often being vegetables, potatoes, and fruits, which have a high potassium content that
may potentially aggravate hyperkalemia. The routine omission of vegetables and fruits from the diet based simply on
their potassium content should be discouraged, considering
that the bioavailability of potassium in unprocessed plant
foods is no more than 60% [74]. These foods also offer other
nutritional benefits such as vitamins, minerals, and fiber.
For adults, Kidney Disease Improving Global Outcomes
(KDIGO) suggests an overall healthy dietary pattern promoting low potassium plant-based foods, especially vegetables
[75]. It has also been suggested that it may be beneficial to
choose foods with a low potassium to fiber ratio to enable
a higher fiber intake to be maintained while lowering dietary potassium [76]. There is no reason why infants should
not benefit from a diet rich in fruits, vegetables, and whole
grains.
Fruits and vegetables with a lower potassium content can
be offered (Table 8), along with advice on portion size of
other high nutritional value foods with a high potassium
content: meat, poultry, fish, eggs, pulses (peas, beans, lentils) and cereals (grains). The potassium content of refined
cereals is lower than whole grain varieties, but the bioavailability of potassium may be higher; they are also lower in
other essential nutrients and fiber, so they may not be the
preferred choice. Families may find it helpful to have lists of
foods with low, moderate, and high potassium content with a
daily allowance of each category. However, it is not usually
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necessary to offer this as the infant’s appetite is generally
low and the small amounts of foods taken are of no concern.
Cooking methods can reduce the high potassium content
of potatoes and other tuberous roots and legumes; cooking
in ample water reduces potassium content by 35–80% while
soaking raw food has very little effect [70, 77–88]. Cutting
potatoes into small pieces and then double-cooking (bringing the water to a boil and then replacing it with fresh water)
reduces the potassium content further [81, 82]. Microwave
cooking reduces the potassium content of foods, but to a
lesser extent than boiling [87]. Sous-vide cooking [89] and
frying [85] increase potassium content of foods. Caregivers
should be advised about these cooking methods by a dietitian, as boiling also reduces the amounts of other minerals
and water-soluble vitamins.
Once the infant is taking a mixed diet, the use of renalspecific low potassium IF instead of whey-dominant IF
allows for the inclusion and greater variety of high potassium foods. Processed foods containing potassium additives
should be avoided as they provide an unnecessary source
of potassium with high (90–100%) bioavailability [90, 91].
In the case of hypokalemia, the initial approach is to
address any medical causes, such as excessive dialysate
potassium losses, medications (potassium binding resins,
diuretics), gastrointestinal losses (vomiting, diarrhea), or
metabolic alkalosis. Severe, life-threatening hypokalemia
requires prompt medical intervention, usually with intravenous potassium infusion. If there is persistent hypokalemia,
dietary potassium intake should be increased by including
higher potassium-containing foods. If a low potassium IF
formula is being used, this should be changed to a wheydominant IF in a stepwise fashion.

Sodium
Polyuric infants with CKD have excessive urinary salt losses
and may require sodium supplements (sodium chloride or
sodium with a base if metabolic acidosis is also present) to
replace these losses. When complementary solid foods are
introduced, these infants often prefer salty tastes. Alternatively, infants with CKD4–5D may have sodium and fluid
retention, which can result in volume overload, edema and
hypertension. Breastmilk and whey-dominant IF should continue as the source of nutrition for the young infant as they
are low in sodium (around 15 mg/100 mL) content. For the
older infant, home-prepared foods are usually low in sodium,
provided no salt is added, and salty foods, e.g., cheese and
processed meats and fish, should be avoided. The content
of commercial weaning foods is regulated, and they are low
in salt.
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Key summary points
• Breastmilk or whey-dominant infant formula are the pre-

ferred feeds for infants with CKD.

• Infants are at risk for growth failure. Measure euvolemic
•

•

•

•
•

(dry) weight, length and head circumference at frequent
intervals and plot on growth charts.
Commence nutritional supplementation as soon as weight
begins to falter. Poor nutritional intake in the first year
of life may lead to irreversible loss of final adult height
potential.
Prepare complementary solids from freshly-cooked foods
to avoid potassium and phosphate additives, and salt,
which are commonly added to processed foods. Offer a
healthy balanced diet with a wide range of food choices,
tastes and textures to promote the development of oral
motor skills and reduce the risk of feeding problems.
Dietary modifications can help maintain serum levels of
potassium, calcium and phosphate within age-appropriate normal ranges. Dietary intervention should be based
on serial serum measurements.
Initiate enteral tube feeding when the infant struggles to
take sufficient nutrition by mouth.
Ideally, infants with CKD are best cared for in a center
with a pediatric renal dietitian who works closely with
physicians to ensure optimal nutritional management.

Multiple choice questions
1. Which of the following statements is true?
a) The infant’s weight, length and weight-for-length
need only be measured when there are concerns
about growth.
b) The infant’s euvolemic weight, length and head
circumference should be measured frequently and
plotted on WHO growth charts.
c) True gain in body weight in infants on peritoneal
dialysis cannot be distinguished from fluid retention.
d) An infant’s failure to gain weight is not a signal for
nutritional intervention.
2. Which of the following statements is true?
a) The energy and protein intake for the conservatively
managed infant with CKD should approximate that
of the healthy infant.
b) The energy and protein intake for the conservatively
managed infant with CKD should be 150% higher
than the requirements of the healthy infant.
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c) Infants with CKD on peritoneal dialysis require a
lower protein intake than infants managed conservatively.
d) The energy derived from glucose in the dialysate
should not be included in the energy intake for the
infant on peritoneal dialysis.
3. Which of the following statements is true?
a) Infants with CKD should be fed a renal-specific low
potassium formula from birth.
b) Infants with CKD can have cow’s milk as their main
drink from 6 months of age.
c) Breast milk or whey-dominant infant formula are the
preferred feeds for infants with CKD throughout the
first year.
d) Casein-dominant infant formulas have a nutritional
profile closest to breast milk.
4. Which of the following statements is true?
a) Infants with CKD should have a healthy balanced
diet avoiding sugars, fats and salt.
b) Infants with CKD should avoid foods high in calcium, phosphate and potassium.
c) Modification of the calcium, phosphate and potassium content of the diet of the infant with CKD can
help maintain normal serum ranges.
d) The introduction of solid foods should be delayed in
the infant with CKD.
5. Which of the following statements is true?
a) As soon as the infant’s weight starts to falter, start
enteral tube feeding.
b) As soon as the infant’s weight starts to falter restrict
the intake of phosphate and potassium.
c) As soon as the infant’s weight starts to falter, start
peritoneal dialysis.
d) As soon as the infant’s weight starts to falter, start
nutritional supplementation of oral feeds and solid
foods.
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